GSK claims first positive Phase 3 result for an RSV vaccine
BioPharma
Source: biopharmadive.com
Page 10 - Hal Barron News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hal Barron. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hal Barron Today - Breaking & Trending Today
GSK announces positive pivotal phase III data for its respiratory syncytial virus (RSV) vaccine candidate for older adults
First RSV vaccine candidate to show statistically significant and clinically meaningful efficacy in adults aged 60 years and above The magnitude of effect observed was consistent across RSV A and B strains, key secondary endpoints and in those aged 70 years and above Engagement with regulators to start immediately with anticipated regulatory submis
Source: pressreleasepoint.com
GSK positive results for phase III RSV vaccine candidate - DirectorsTalk Interviews
GSK positive results for phase III RSV vaccine candidate
Source: directorstalkinterviews.com
Investegate |GSK PLC Announcements | GSK PLC: Positive phase III data for GSK's RSV OA vaccine
Investegate announcements from GSK PLC, Positive phase III data for GSK's RSV OA vaccine
Source: investegate.co.uk
GSK aims to deliver first RSV vaccine after positive results
RSV remains one of the few major infectious diseases without a vaccine.
Source: moneyweb.co.za